TEDA BIOMEDICAL: (1) CONNECTED TRANSACTIONS IN RELATION TO THE ENTERING INTO OF THE AGREEMENTS (2) VARIATION OF TERMS OF MAJOR TRANSACTION IN RELATION TO THE ACQUISITION OF 51% SHAREHOLDING INTEREST IN SJKGC (3) DISCLOSEABLE TRANSACTION IN RELATION TO THE

Mar 26, 2021 22:54

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

泰達生物：(1)有關訂立該等協議之關連交易 (2)修改有關收購SJKGC之51%股權之主要交易之條款 (3)有關SJK向香港泰達轉讓SJKGC的39%股權的須予 披露交易

TEDA BIOMEDICAL: (1) CONNECTED TRANSACTIONS IN RELATION TO THE ENTERING INTO OF THE AGREEMENTS (2) VARIATION OF TERMS OF MAJOR TRANSACTION IN RELATION TO THE ACQUISITION OF 51% SHAREHOLDING INTEREST IN SJKGC (3) DISCLOSEABLE TRANSACTION IN RELATION TO THE

Risk Disclaimer

Statement

泰達生物：(1)有關訂立該等協議之關連交易 (2)修改有關收購SJKGC之51%股權之主要交易之條款 (3)有關SJK向香港泰達轉讓SJKGC的39%股權的須予披露交易